Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Oncology (Williston Park, N.Y.)|June 9, 2001
New combinations with epirubicin in advanced breast cancerP Conte, A Gennari, E Landucci, et al.
Journal of Hepatology|August 1, 1995
Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosisM Zoli, D Magalotti, G Bianchi, et al.
Physics in Medicine and Biology|August 30, 2008
A mathematical approach for evaluating the influence of dose heterogeneity on TCP for prostate cancer brachytherapy treatmentL Strigari, L C Orlandini, I Andriani, et al.
Oncology (Williston Park, N.Y.)|June 9, 2001
Epirubicin/taxane combinations in breast cancer: experience from several Italian trialsP Conte, A Gennari, V Guarneri, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|March 3, 2015
Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptomsS Pinzauti, L Lazzeri, C Tosti, et al.
American Journal of Clinical Oncology|August 24, 2000
Long-acting depot lanreotide in the treatment of patients with advanced neuroendocrine tumorsS Ricci, A Antonuzzo, L Galli, et al.
Bone Marrow Transplantation|July 27, 2004
HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell supportV Guarneri, C Bengala, C Orlandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
Cardiotoxicity of epirubicin/paclitaxel-containing regimens: role of cardiac risk factorsA Gennari, B Salvadori, S Donati, et al.
British Journal of Cancer|March 5, 2004
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapyA Gennari, P Bruzzi, C Orlandini, et al.
Cancer|October 24, 2000
A randomized study comparing two different schedules of administration of cisplatin in combination with gemcitabine in advanced nonsmall cell lung carcinomaS Ricci, A Antonuzzo, L Galli, et al.
Pageof 5